Navigation Links
AdvaMed Selects Prolifiq as Member of Business Solutions Program
Date:3/23/2010

BEAVERTON, Ore., March 23 /PRNewswire/ -- Prolifiq, the leading provider of Sales Content Management software for medical device companies, today announced it has been selected by the Advanced Medical Technology Association (AdvaMed), as a member of the organization's Business Solutions Program.

Prolifiq's software is used by sales, marketing, and regulatory personnel to manage and deliver promotional and scientific information to health care practitioners. The company's offering simplifies the management of selling collateral, and embeds important compliance safeguards into sales communication workflows.  

"AdvaMed members are committed to the highest ethical standards when it comes to the delivery of information to health care providers and Prolifiq's software is an important step toward implementing a comprehensive Good Promotional Practices program," said Jeff Gaus, CEO of Prolifiq Software.

The AdvaMed Business Solutions program provides member companies access to several quality products and services. Members enjoy benefits including dedicated service lines and discounted prices. Other offerings include liability insurance, medical translation services, industry research publications and logistical support for expanding i
'/>"/>

SOURCE Prolifiq
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
2. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
3. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
4. AdvaMed Releases New Survey Results on DTC Campaigns
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
7. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
8. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
9. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
10. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
11. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Alemania, December 17, 2014 Los ... con un alto nivel de gasto en investigación y ... 2013/14 (finalizado el 30 de septiembre de 2014) ZEISS ... 4.287 millones de euros (año anterior: 4.190 millones de ... desfavorables. Las ganancias (EBIT) crecieron un 14 por ciento, ...
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... and RALEIGH, N.C. ... Marketing Communications, LLC (CTMC), and Integrated Clinical Trial ... recruitment and retention for clinical trials announce that ... Clinical Trial Marketing Services (i-CTMS). i-CTMS will provide ... services to pharmaceutical, biotechnology and medical device companies. ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... shows that loss of Arf gene in presence ... growth-enhancing environment of the bone,marrow, helping cells develop ... Tenn., Aug. 29 Results of a study,by ... strong,evidence for why the drug imatinib (Gleevec(TM)), which ...
... First-In-Human Study to Cancer Patients, SALT LAKE ... that its first-in-humans Phase 1 study of PRLX ... evaluate the safety,pharmacokinetic and pharmacodynamic properties of PRLX ... include TGen Clinical Research at,Scottsdale Healthcare in Scottsdale, ...
Cached Medicine Technology:St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia 2Prolexys Pharmaceuticals Initiates Phase 1 Study 2
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Traveling through the ... measles virus to three others within a four-hour time ... a new report shows. "The exposures in this ... rather than an international terminal, highlighting the fact that ... Jared Vega, an infectious disease specialist at the U.S. ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 ... for at least 20 seconds you may be at risk ... one leg may indicate that small strokes or tiny bleeds ... strokes is high, the investigators reported online Dec. 18 in ... standing on one leg, as well as problems walking, should ...
(Date:12/17/2014)... 2014 Dr. Myo Nwe is the co-author ... of the Future” and co-founder of the Ace Medical Weight ... Nwe takes a broad look at the industry of weight ... scientific scrutiny. On film and in television shows, however, she ... the social aspects and played for basic laughs, which she ...
(Date:12/17/2014)... RI (PRWEB) December 17, 2014 ... recognize private practices that have made outstanding and ... in support and progression of private practice physical ... American Physical Therapy Association. , On behalf of ... OCS, owner and CEO of Performance accepted the ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 A group of ... for Longevity, today, in reaction to a recent statement by ... of brain training and derogated the efficacy of all brain ... agreed with the parts of the center’s statement critical of ... the center had also overstated its case, in a document ...
Breaking Medicine News(10 mins):Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4
... But these side effects are rare and benefits still ... News) -- Cholesterol-lowering statins could raise the risk for ... suggests that statin-attributed tendinous complications are rare, considering the ... University Hospital. , Reporting in the March issue of ...
... The American people,through the United States ... of four partners, will assist in building ... prevention, malaria and child,survival programs. The Behavior ... district stakeholders, the private sector and Government ...
... COLUMBUS, Ohio A study published in the February ... sports injuries in U.S. high schools in 2005-2007 were ... activity by a referee, official or disciplinary committee. , ... (CIRP) at Nationwide Childrens Hospital analyzed data from the ...
... 15 years in the,European Community, The Skin Care ... Friendly Inc. to expand its clinically proven,products to ... shares its efforts in providing quality and advanced ... national launch of Skin Protect lotion.,According to Skin ...
... Inc. (Amex: BUF ) announced the start ... South Africa. The event,will continue through March 2, ... panel discussions by distinguished physicians and,researchers on topics ... The Meeting will be opened with a presentation ...
... damage begins at blood sugar levels below current threshold ... News) -- Fasting blood sugar levels are typically used ... disease that can lead to blindness begins at blood ... report. , Retinopathy is a vascular condition where the ...
Cached Medicine News:Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 3Health News:USAID Implements Behavior Change and Social Marketing Program in Rwanda 2Health News:When the rules of the game are broken: Research studies sports injuries related to illegal activity 2Health News:Skin Friendly Releases Clinically Proven Hypoallergenic Anti-Bacterial Barrier Lotion 2Health News:MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa 2Health News:MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa 3Health News:Marker for Diabetes Might Miss Early Vision Complication 2
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 9" handle....
9.5" overall length, 4.5" handle....
...
Medicine Products: